EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Performance and Sensitivity of [ 99m Tc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver

Irene Hernández-Lozano, Sarah Leterrier, Severin Mairinger, Johann Stanek, Anna S Zacher, Lara Breyer, Marcus Hacker, Markus Zeitlinger, Jens Pahnke, Nicolas Tournier, Thomas Wanek, Oliver Langer iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.3c01036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Irene Hernández-Lozano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Member 1, Metoclopramide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Agence Nationale de la Recherche, Bundesministerium f?r Bildung und Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P-glycoprotein (P-gp, encoded in humans by the ABCB1 gene and in rodents by the Abcb1a/b genes) is a membrane transporter that can restrict the intestinal absorption and tissue distribution of many drugs and may also contribute to renal and hepatobiliary drug excretion. The aim of this study was to compare the performance and sensitivity of currently available radiolabeled P-gp substrates for positron emission tomography (PET) with the single-photon emission computed tomography (SPECT) radiotracer [99mTc]Tc-sestamibi for measuring the P-gp function in the kidneys and liver. Wild-type, heterozygous (Abcb1a/b(+/-)), and homozygous (Abcb1a/b(-/-)) Abcb1a/b knockout mice were used as models of different P-gp abundance in excretory organs. Animals underwent either dynamic PET scans after intravenous injection of [11C]N-desmethyl-loperamide, (R)-[11C]verapamil, or [11C]metoclopramide or consecutive static SPECT scans after intravenous injection of [99mTc]Tc-sestamibi. P-gp in the kidneys and liver of the mouse models was analyzed with immunofluorescence labeling and Western blotting. In the kidneys, Abcb1a/b() mice had intermediate P-gp abundance compared with wild-type and Abcb1a/b(-/-) mice. Among the four tested radiotracers, renal clearance of radioactivity (CLurine,kidney) was significantly reduced (-83%) in Abcb1a/b(-/-) mice only for [99mTc]Tc-sestamibi. Biliary clearance of radioactivity (CLbile,liver) was significantly reduced in Abcb1a/b(-/-) mice for [11C]N-desmethyl-loperamide (-47%), [11C]metoclopramide (-25%), and [99mTc]Tc-sestamibi (-79%). However, in Abcb1a/b(+/-) mice, CLbile,liver was significantly reduced (-47%) only for [99mTc]Tc-sestamibi. Among the tested radiotracers, [99mTc]Tc-sestamibi performed best in measuring the P-gp function in the kidneys and liver. Owing to its widespread clinical availability, [99mTc]Tc-sestamibi represents a promising probe substrate to assess systemic P-gp-mediated drug-drug interactions and to measure renal and hepatic P-gp function under different (patho-)physiological conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily B, Member 1MetoclopramideHumansMiceAnimalsTomography, X-Ray ComputedATP Binding Cassette Transporter, Subfamily BPositron-Emission TomographyRadiopharmaceuticalsLiverTomography, Emission-Computed, Single-PhotonKidneyNitrilesOrganotechnetium CompoundsMice, Knockout

Stichwörter der Autor:innen

P-glycoproteinPETSPECT[99 mTc]Tc-sestamibidrug–drug interactionprobe substrate

Substanzen

ATP Binding Cassette Transporter, Subfamily B, Member 1MetoclopramideATP Binding Cassette Transporter, Subfamily BRadiopharmaceuticalsNitrilesOrganotechnetium Compounds

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
  • Laboratoire d'Imagerie Biomédicale Multimodale (BIOMAPS), Université Paris-Saclay, CEA, CNRS, Inserm, Service Hospitalier Frédéric Joliot, 91401 Orsay, France.
  • Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
  • Department of Pathology, Section of Neuropathology, Translational Neurodegeneration Research and Neuropathology Lab, University of Oslo (UiO) and Oslo University Hospital (OUS), 0372 Oslo, Norway.
  • Lübeck Institute of Experimental Dermatology (LIED), Pahnke Lab, University of Lübeck and University Medical Center Schleswig-Holstein, 23538 Lübeck, Germany.
  • Department of Pharmacology, Faculty of Medicine, University of Latvia, 1004 Ri̅ga, Latvia.

ORCID-Profile: Oliver Langer

Förderung

  • Austrian Science Fund FWF
  • Agence Nationale de la Recherche
  • Bundesministerium f?r Bildung und Forschung
  • Vetenskapsr?det
  • State Education Development Agency Republic of Latvia
  • ?sterreichische Forschungsf?rderungsgesellschaft
  • Norges Forskningsr?d
  • Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy

Zitieren

APA

Hernández-Lozano, I., Leterrier, S., Mairinger, S., Stanek, J., Zacher, A. S., Breyer, L., Hacker, M., Zeitlinger, M., Pahnke, J., Tournier, N., Wanek, T., & Langer, O. (2024). Performance and Sensitivity of [ 99m Tc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01036

Vancouver

Hernández-Lozano I, Leterrier S, Mairinger S, Stanek J, Zacher AS, Breyer L, et al. Performance and Sensitivity of [ 99m Tc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01036

BibTeX
@article{HernndezLozano2024,
  author = {Hernández-Lozano, Irene and Leterrier, Sarah and Mairinger, Severin and Stanek, Johann and Zacher, Anna S and Breyer, Lara and Hacker, Marcus and Zeitlinger, Markus and Pahnke, Jens and Tournier, Nicolas and Wanek, Thomas and Langer, Oliver},
  title = {Performance and Sensitivity of [ 99m Tc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.3c01036}
}
Kostenlos starten →